Trailing Twelve Months Revenue Growth: G1 Therapeutics, Inc. (GTHX)

Public company logo of G1 Therapeutics Inc. (GTHX)

G1 Therapeutics, Inc. (GTHX) relies on a highly scalable model: following patent registration, drug production costs decrease, thereby increasing profits. The annual revenue growth rate (rolling period) confirms this trend, where the value of 66.40 expresses the metric level. Physician confidence is based on drug safety, while streamlined logistics hubs guarantee the uninterrupted supply of oncology medications.

G1 Therapeutics (GTHX): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 02/20/2024

G1 Therapeutics - analytical breakdowns and key metrics (GTHX)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:g1therapeutics.com
Brand item of g1therapeutics.com

This indicator measures revenue dynamics over a rolling twelve-month period, reflecting the actual growth rate of income through the continuous discounting of G1 Therapeutics (GTHX) market prospects. By analyzing the year-over-year sales trajectory (TTM), an investor can assess the impact of a technological lull and the freeze of R&D programs on the fundamental stability of the business during a period of large-scale asset restructuring.

Who G1 Therapeutics, Inc. competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) CRDF (cardiffoncology.com)|BYSI: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth BioAtla Corp (BCAB)|Sales Growth YoY (Last Twelve Months) Lixte Biotechnology Holdings, Inc.|CTXR: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) CLRB|Sales Growth YoY (TTM) BioLineRx Corporation (BLRX)|Sales Growth YoY (Last Twelve Months) Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Trailing Twelve Months Sales Growth|KZIA: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Silexion Therapeutics|NuCana plc (NCNA) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Chimerix, Inc|Revenue Growth YoY (Last 12 Months) CYCC|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)